| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/01/2002 | DE10101307A1 Fumarsäurederivate als NF-kappaB-Inhibitor Fumaric acid derivatives as NF-kappaB inhibitor |
| 08/01/2002 | CA2735478A1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 08/01/2002 | CA2735267A1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 08/01/2002 | CA2563051A1 Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 08/01/2002 | CA2436076A1 Use of compositions containing pdgf-bb for promoting angiogenesis |
| 08/01/2002 | CA2435884A1 Process for the preparation of a pyrazolo[4,3-d]pyrimidine derivative |
| 08/01/2002 | CA2435876A1 The treatment of sexual dysfunction and cardiovascular disease with quinolinone enantiomers |
| 08/01/2002 | CA2435829A1 Trisubstituted carbocyclic cyclophilin binding compounds and their use |
| 08/01/2002 | CA2435775A1 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof |
| 08/01/2002 | CA2435647A1 Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and use |
| 08/01/2002 | CA2435566A1 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 08/01/2002 | CA2435562A1 Carotenoids as anti-hypertension agents |
| 08/01/2002 | CA2435047A1 Constitutively desensitized g protein-coupled receptors |
| 08/01/2002 | CA2434558A1 Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 08/01/2002 | CA2434504A1 Combinations of sterol absorption inhibitor(s) with blood modifiers for treating vascular conditions |
| 08/01/2002 | CA2434488A1 Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(s) and treatments for vascular indications |
| 08/01/2002 | CA2434436A1 Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions |
| 08/01/2002 | CA2434430A1 The use of substituted azetidinone compounds for the treatment of sitosterolemia |
| 08/01/2002 | CA2434050A1 Herbal composition for angina pectoris, method to prepare same and uses thereof |
| 08/01/2002 | CA2434033A1 Combinations of bile acid sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 08/01/2002 | CA2433762A1 Essential n-3 fatty acids in cardiac insufficiency and heart failure therapy |
| 08/01/2002 | CA2433681A1 Sulfatases and methods of use thereof |
| 08/01/2002 | CA2433530A1 New film coating |
| 08/01/2002 | CA2432134A1 Adenylate cyclases |
| 08/01/2002 | CA2427061A1 Methods and compositions for the identification and treatment of neurodegenerative disorders |
| 08/01/2002 | CA2426102A1 Method of diagnosing and treating cartilaginous disorders |
| 07/31/2002 | EP1227099A1 Fused Pyrazolyl compounds |
| 07/31/2002 | EP1227098A1 Triazolopurine derivatives, drug compositions containing the same and adenosine a3 receptor affinitive agents |
| 07/31/2002 | EP1227092A2 Isonitrile intermediates for the preparation of tri-substituted imidazole compounds with multiple therapeutic properties |
| 07/31/2002 | EP1227091A2 Formamide intermediates for the preparation of tri-substituted imidazole compounds with multiple therapeutic properties |
| 07/31/2002 | EP1227083A1 3-AMINOPIPERIDINE DERIVATIVES AS INTEGRIN $g(a)v$g(b)3 ANTAGONISTS |
| 07/31/2002 | EP1226830A2 Combination therapy involving a sodium-hydrogen exchanger type 1 or NHE-1 inhibitor for use in treatment of ischemia |
| 07/31/2002 | EP1226829A2 Stabilised liquid preparations of the protease or its proenzyme which activitate the blood coagulation factor VII |
| 07/31/2002 | EP1226822A2 Promoter for production of nitric oxide or nitric oxide synthase, and cosmetic or pharmaceutical composition comprising the same |
| 07/31/2002 | EP1226435A1 Axor35, a g-protein coupled receptor |
| 07/31/2002 | EP1226433A1 Method for identifying active anti-apoptosis compounds |
| 07/31/2002 | EP1226267A1 Process for producing a product containing antihypertensive tripeptides |
| 07/31/2002 | EP1226252A2 DOUBLE-STRANDED RNA RECEPTOR (dsRNA-R) AND METHODS RELATING THERETO |
| 07/31/2002 | EP1226251A2 CpG RECEPTOR (CpG-R) AND METHODS RELATING THERETO |
| 07/31/2002 | EP1226249A2 Follistatin-related protein zfsta4 |
| 07/31/2002 | EP1226247A1 Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences |
| 07/31/2002 | EP1226243A2 Nucleic acid molecules derived from rat brain and programmed cell death models |
| 07/31/2002 | EP1226242A1 Human cub-domain-containing protein and gene encoding the same |
| 07/31/2002 | EP1226239A1 Methods of producing differentiated progenitor cells and lineage-defective embryonic stem cells |
| 07/31/2002 | EP1226237A2 Method of identifying inhibitors of cdc25 |
| 07/31/2002 | EP1226231A1 19 human secreted proteins |
| 07/31/2002 | EP1226230A1 Lactobacillus helveticus producing antihypertensive di- and tripeptides |
| 07/31/2002 | EP1226160A2 Novel antiarrhythmic peptides |
| 07/31/2002 | EP1226159A1 Substituted dipeptides having nos inhibiting activity |
| 07/31/2002 | EP1226155A2 18-nor-steroids as selectively active estrogens |
| 07/31/2002 | EP1226154A1 Estradiol conjugates and uses thereof |
| 07/31/2002 | EP1226148A2 Novel oligosaccharides, preparation method and pharmaceutical compositions containing same |
| 07/31/2002 | EP1226144A1 Alkylamino substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 07/31/2002 | EP1226143A2 Imidazopyridine derivatives used as phosphodiesterase vii inhibitors |
| 07/31/2002 | EP1226141A1 Heterocyclic substituted pyrazolones |
| 07/31/2002 | EP1226137A1 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity |
| 07/31/2002 | EP1226136A2 Tyrosine kinase inhibitors |
| 07/31/2002 | EP1226132A1 Nonpeptide substituted benzothiazepines as vasopressin antagonists |
| 07/31/2002 | EP1226131A2 Isoxazolecarboxamide derivatives |
| 07/31/2002 | EP1226129A1 Methods and compositions utilizing quinazolinones |
| 07/31/2002 | EP1226126A1 Pyrimidine derivatives |
| 07/31/2002 | EP1226124A1 Heterocyclically substituted benzoylguanidine, method for the production thereof, the use thereof as a medicament or means of diagnosis and a medicament containing the same |
| 07/31/2002 | EP1226119A2 Tyrosine kinase inhibitors |
| 07/31/2002 | EP1226115A1 Novel carbamates and ureas |
| 07/31/2002 | EP1226112A2 Retro-anandamides, high affinity and stability cannabinoid receptor ligands |
| 07/31/2002 | EP1226110A1 Bicyclic amino acids as pharmaceutical agents |
| 07/31/2002 | EP1225922A1 Selective toxin expression in angiogenic endothelial cells |
| 07/31/2002 | EP1225921A1 TECHNIQUES AND COMPOSITIONS FOR TREATING CARDIOVASCULAR DISEASE BY i IN VIVO /i GENE DELIVERY |
| 07/31/2002 | EP1225915A2 Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies |
| 07/31/2002 | EP1225910A2 MODULATION OF eNOS ACTIVITY AND THERAPEUTIC USES THEREOF |
| 07/31/2002 | EP1225901A2 Uses and compositions for treating platelet-related disorders using anagrelide |
| 07/31/2002 | EP1225900A1 Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders |
| 07/31/2002 | EP1225896A1 Isoxazole derivatives to be used as phosphodiesterase vii inhibitors |
| 07/31/2002 | EP1225883A1 Anti-ischemic compounds |
| 07/31/2002 | EP1225813A1 Cholesterol reducing stanol compositions, preparation and method of use |
| 07/31/2002 | EP1225810A1 Method for treatment of chronic venous insufficiencies using an extract of red vine leaves |
| 07/31/2002 | EP0958290B1 1,4-dihydropyridin derivatives and their use in therapy |
| 07/31/2002 | EP0825848B1 Translucent collagen formulations |
| 07/31/2002 | EP0755930B1 Benzoxazepine derivatives, salts thereof, and drugs containing the same |
| 07/31/2002 | EP0527801B1 Thiophene sulfonamides useful as carbonic anhydrase inhibitors |
| 07/31/2002 | CN1361792A Cyclic peptide derivatives as inhibitors of integrin alpha/beta |
| 07/31/2002 | CN1361783A Thiazoloderivatives and pharmaceutical compositions containing them |
| 07/31/2002 | CN1361782A Substituted imidazothiazoles as antidepressant agents |
| 07/31/2002 | CN1361781A Oxazinocarbazoles for the treatment of CNS diseases |
| 07/31/2002 | CN1361776A Novel fluorinated imidazoline Benzodioxane, preparation and therapeutic uses thereof |
| 07/31/2002 | CN1361773A Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods |
| 07/31/2002 | CN1361767A 1,4,5,6-tetrahydropyrimidine derivative as a vitronectin inhibitor |
| 07/31/2002 | CN1361763A Aminobenzophenones as inhibitors of IL-1 beta and TNF_alpha |
| 07/31/2002 | CN1361760A Novel interleukin-1 and tumor necrosis factor-alpha modulators, syntheses of said modulators and methods of using said modulators |
| 07/31/2002 | CN1361690A Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents |
| 07/31/2002 | CN1361689A Stable xylometazoline and oxymetazoline solution |
| 07/31/2002 | CN1361111A Furost saponine analogue and its separation process and use |
| 07/31/2002 | CN1361098A Prepn of chiral compound L-homophenprobamate and its salt |
| 07/31/2002 | CN1360908A Chinese traditional medicine prepn for preventing and/or treating irritable myocardial injury |
| 07/31/2002 | CN1360901A Snuff xinnaokang for treating cardiovascular and cerebrovascular disease |
| 07/31/2002 | CN1360900A Medicine for treating congestive heart failure and its prepn |
| 07/31/2002 | CN1360898A Prepn of Baoxinning tablet as angiocardiopathy treating medicine |
| 07/31/2002 | CN1088456C Substituted oxazolidine calpain and/or cathepsin B inhibitors |
| 07/31/2002 | CN1088374C Food ingredients of beneficial for coronary heart diseases and tumor patients |
| 07/31/2002 | CN1088364C Traditional Chinese medicine composition for treating ischemic encephalopathy and preparation process thereof |